The TGA published information about its regulatory changes to up-classify surgical mesh devices and options for practitioners or hospitals seeking to use cancelled devices.
The Royal Australian College of General Practitioners (RACGP) published an article on what GPs need to know about the Senate inquiry into urogynaecological mesh implants. It includes information on how the outcome of the inquiry will impact future treatment options and how GPs can approach treatment of affected women.
The RACGP produced the webinar, Stress Urinary Incontinence & Aiding Patient Decision Making, in September 2018.
The Australian Commission on Safety and Quality in Health Care developed resources for consumers, clinicians and health service organisations on urogynaecological mesh , including information on care pathways for the management of pelvic organ prolapse and stress urinary incontinence. They also include guidance for hospitals on the credentialing of senior medical practitioners to implant and remove urogynaecological mesh for treatment of pelvic organ prolapse and stress urinary incontinence.
NSW Health has published information for general practitioners regarding mesh implant for pelvic organ prolapse. This fact sheet covers tips for GPs treating women with symptomatic pelvic organ prolapse, and women who have a urogynaecological mesh implant, with or without possible complications.
On 20 December 2017, NSW Health issued a safety notice (SN:015/17) on urogynaecological mesh implants for pelvic organ (vaginal) prolapse. It discusses background information on the use of mesh products, surgeon experience and patient selection, and informed consent. It also links to the 2017 TGA alert, 'TGA actions after review into urogynaecological surgical mesh implants'.
The NSW Agency for Clinical Innovation developed a Decision Aid for Women Experiencing Stress Urinary Incontinence, and an overview of options for managing the condition.
Health Victoria published a fact sheet on urogynaecological mesh complications, including the signs, symptoms and treatment options for affected women.